1. bookVolume 3 (2020): Edition 2 (December 2020)
Détails du magazine
Première parution
30 Apr 2019
2 fois par an
Accès libre

Unsafe Ingredients Included in Malaysian Food Drug Interphase (FDI) Products: Toyyiban perspective

Publié en ligne: 17 Aug 2020
Volume & Edition: Volume 3 (2020) - Edition 2 (December 2020)
Pages: 63 - 68
Détails du magazine
Première parution
30 Apr 2019
2 fois par an

[1] B. Niggemann, C. Gruber, “National Pharmaceutical Regulatory Agency Ministry Of Health, Malaysia, Drug Registration Guidance Document (DRGD) Side-effects of complementary and alternative medicine”, Allergy, Vol. 58, No. 8, Pp. 707-716, 2003.10.1034/j.1398-9995.2003.00219.xSearch in Google Scholar

[2] I. Houssien, Small and medium enterprises and access to finance in Egypt, 2014.Search in Google Scholar

[3] K. Hussain, M.T. Majeed, Z. Ismail, A. Sadikun, A. Ibrahim, “Traditional and complementary medicines: Quality assessment strategies and safe usage”, Southern Med Review, Vol. 2, No. 1, Pp. 19-23, 2009.Search in Google Scholar

[4] A. Palanisamy, C. Haller, K.R. Olson, “Photosensitivity reaction in a woman using an herbal supplement containing ginseng, goldenseal, and bee pollen”, Journal of Toxicology: Clinical Toxicology, Vol. 41, No. 6, Pp. 865-867, 2003.10.1081/CLT-120025353Search in Google Scholar

[5] A.I. Geller, N. Shehab, N.J. Weidle, M.C. Lovegrove, B.J. Wolpert, B.B. Timbo, D.S. Budnitz, “Emergency department visits for adverse events related to dietary supplements”, New England Journal of Medicine, Vol. 373, No. 16, Pp. 1531-1540, 2015.Search in Google Scholar

[6] Dietary supplement, Food Facts, U.S Food & Drug Administration. Retrieved from https://www.fda.gov/downloads/Food/DietarySupplements/UCM240978.pdfSearch in Google Scholar

[7] P. Jayaraj, “Regulation of traditional and complementary medicinal products in Malaysia”, International Journal of Green Pharmacy, Vol. 4, No. 1, Pp. 10, 2010.10.4103/0973-8258.62158Search in Google Scholar

[8] E.O. Meltzer, G.D. Berman, J. Corren, A.J. Pedinoff, G. Doyle, J.A. Waksman, S. Wason, “Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis”, Annals of Allergy, Asthma & Immunology, Vol. 93, No. 5, Pp. 452-459, 2004.10.1016/S1081-1206(10)61412-3Search in Google Scholar

[9] N.K. Lariya, G.P. Agrawal, “Development and validation of RP-HPLC method for simultaneous determination of methotrexate, dexamethasone and indomethacin”, International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 7, No. 3, Pp. 443-446, 2014.Search in Google Scholar

[10] M.E. Parsons, C.R. Ganellin, “Histamine and its receptors”, British journal of pharmacology, Vol. 147, No. S1, Pp. S127-S135, 2006.10.1038/sj.bjp.0706440176072116402096Search in Google Scholar

[11] N.H. Waldron, C.A. Jones, T.J. Gan, T.K. Allen, A.S. Habib, “Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis”, British journal of anaesthesia, Vol. 110, No. 2, Pp. 191-200, 2012.10.1093/bja/aes431354400823220857Search in Google Scholar

[12] M.S. Wong, “Pocket orthopaedics: evidence-based survival guide: evidence-based survival guide”, Jones & Bartlett Publishers, 2009.Search in Google Scholar

[13] Malaysian Standard. “Halal Pharmaceuticals general guidelines”, Malaysian Standard MS 2424, Department of Standards, Malaysia, 2010.Search in Google Scholar

[14] A. Sarriff, “Exploring the halal status of cardiovascular, endocrine, and respiratory group of medications”, The Malaysian journal of medical sciences: MJMS, Vol. 20, No. 1, Pp. 69, 2013.Search in Google Scholar

[15] T.M. Khan, S. Shaharuddin, “Need for contents on halal medicines in pharmacy and medicine curriculum”, Arch Pharm Pract., Vol. 6, Pp. 38-40, 2015.10.4103/2045-080X.155512Search in Google Scholar

[16] N. Noordin, N.L.M. Noor, Z. Samicho, “Strategic approach to halal certification system: An ecosystem perspective”, Procedia-Social and Behavioral Sciences, Vol. 121, Pp. 79-95, 2014.10.1016/j.sbspro.2014.01.1110Search in Google Scholar

[17] H. Suzuki, A. Shigeta, T. Fukunaga, “Accidental death of elderly persons under the influence of chlorpheniramine”, Legal Medicine, Vol. 15, No. 5, Pp. 253-255, 2013.10.1016/j.legalmed.2013.04.00223747192Search in Google Scholar

[18] M. Tagawa, M. Kano, N. Okamura, M. Higuchi, M. Matsuda, Y. Mizuki, T. Ido, “Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine”, British journal of clinical pharmacology, Vol. 52, No. (5), Pp. 501-509, 2001. https://www.adk.gov.my/wp-content/uploads/Buku-Dasar-Dadah-Negara-EN.pdf10.1046/j.1365-2125.2001.01471.x201461611736858Search in Google Scholar

[19] A.C. Deslandes, H. Veiga, M. Cagy, R. Piedade, F. Pompeu, P. Ribeiro, “Effects of caffeine on the electrophysiological, cognitive and motor responses of the central nervous system”, Brazilian Journal of Medical and Biological Research, Vol. 38, No. 7, Pp. 1077-1086, 2005.Search in Google Scholar

[20] G. Fisone, A. Borgkvist, A. Usiello, “Caffeine as a psychomotor stimulant: mechanism of action”, Cellular and Molecular Life Sciences CMLS, Vol. 61, No. 7-8, Pp. 857-872, 2004.10.1007/s00018-003-3269-3Search in Google Scholar

[21] M.E.J. Lean, “How does sibutramine work?”, International Journal of Obesity & Related Metabolic Disorders, Vol. 25, 2001.10.1038/sj.ijo.0801931Search in Google Scholar

[22] R.J. Araujo, F. Martel, “Sibutramine effects on central mechanisms regulating energy homeostasis”, Current neuropharmacology, Vol. 10, No. 1, Pp. 49-52, 2012.10.2174/157015912799362788Search in Google Scholar

[23] E. Wooltorton, “Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias”, Cmaj, Vol. 166, No. 10, Pp. 1307-1308, 2002.Search in Google Scholar

[24] T.M. Saifuddin, N. Rahim, N.Z. Mansor, “Psychosis Associated with Weight-loss Product Containing Sibutramine: A Case Report”, Malaysian Journal of Psychiatry, Vol. 26, No. 2, Pp. 53-56, 2018.Search in Google Scholar

[25] F. Montorsi, H.P. Nathan, A. Mccullough, G.B. Brock, G. Broderick, S. Ahuja, L. Varanese, “Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial”, The Journal of urology, Vol. 172, No. 3, Pp. 1036-1041, 2004.Search in Google Scholar

[26] H. Porst, H. Padma-Nathan, F. Giuliano, G. Anglin, L. Varanese, R. Rosen, “Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial”, Urology, Vol. 62, No. 1, Pp. 121-125, 2003.10.1016/S0090-4295(03)00359-5Search in Google Scholar

[27] S. Takatsuki, M. Calderbank, D.D. Ivy, “Initial experience with tadalafil in pediatric pulmonary arterial hypertension”, Pediatric cardiology, Vol. 33, No. 5, Pp. 683-688, 2012.10.1007/s00246-012-0180-4Search in Google Scholar

[28] J.M. McKoy, C.R. Bolden, A. Samaras, D.W. Raisch, K. Chandler, C.L. Bennett, “Sildenafil-and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment”, Community oncology, Vol. 6, No. 2, Pp. 78, 2009.10.1016/S1548-5315(11)70214-5Search in Google Scholar

[29] N. Galiè, B.H. Brundage, H.A. Ghofrani, R.J. Oudiz, G. Simonneau, Z. Safdar, L. Frumkin, “Tadalafil therapy for pulmonary arterial hypertension”, Circulation, Vol. 119, No. 22, Pp. 2894, 2009.10.1161/CIRCULATIONAHA.108.839274Search in Google Scholar

[30] K.K. Gaines, “For Erectile Dysfunction”, Urologic nursing, Vol. 24, No. 1, 2004.Search in Google Scholar

[31] R. Gazzeri, M. Neroni, M. Galarza, S. Esposito, “Intracerebral hemorrhage associated with use of tadalafil (Cialis)”, Neurology, Vol. 70, No. 15, Pp. 1289-1290.10.1212/01.wnl.0000308939.16685.b6Search in Google Scholar

[32] A.S. Khan, Z. Sheikh, S. Khan, R. Dwivedi, E. Benjamin, “Viagra deafness—Sensorineural hearing loss and phosphodiesterase-5 inhibitors”, The Laryngoscope, Vol. 121, No. 5, Pp. 1049-1054, 2011.Search in Google Scholar

[33] L. Becker, B. Eberlein-König, B. Przybilla, “Phototoxicity of non-steroidal anti-inflammatory drugs: in vitro studies with visible light”, Acta dermatovenereologica, Vol. 76, No. 5, Pp. 337-340, 1996.Search in Google Scholar

[34] D.J. Gordon, U.S. Patent No. 6,022,563. Washington, DC: U.S. Patent and Trademark Office, 2000.Search in Google Scholar

[35] P.J. Neuvonen, E. Elonen, “Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man”, European Journal of Clinical Pharmacology, Vol. 17, No. 1, Pp. 51-57, 1980.10.1007/BF00561677Search in Google Scholar

[36] E.G. Boyce, E.M. Umland, “Sildenafil citrate: a therapeutic update”, Clinical therapeutics, Vol. 23, No. 1, Pp. 2-23, 2001.10.1016/S0149-2918(01)80027-8Search in Google Scholar

[37] S.G. Swearingen, J.D. Klausner, “Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection”, The American journal of medicine, Vol. 118, No. 6, Pp. 571-577, 2005.10.1016/j.amjmed.2005.01.04215922685Search in Google Scholar

[38] I.S. De Tejada, J. Angulo, P. Cuevas, A. Fernandez, I. Moncada, A. Allona, E. Pages, “The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil”, International journal of impotence research, Vol. 13, No. 5, Pp. 282-290, 2001.10.1038/sj.ijir.390072611890515Search in Google Scholar

[39] C. Kruuse, L.L. Thomsen, T.B. Jacobsen, J. Olesen, “The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects”, Journal of Cerebral Blood Flow & Metabolism, Vol. 22, No. 9, Pp. 1124-1131, 2002.Search in Google Scholar

[40] P.P. Khanna, H.S. Gladue, M.K. Singh, J.D. FitzGerald, S. Bae, S. Prakash, R. Terkeltaub, “Treatment of acute gout: a systematic review”, In Seminars in arthritis and rheumatism, Vol. 44, No. 1, Pp. 31-38, 2014.10.1016/j.semarthrit.2014.02.00324650777Search in Google Scholar

[41] C. Rohde, D.E. Anderson, A.L. Bertone, S.E. Weisbrode, S. E. “Effects of phenylbutazone on bone activity and formation in horses”, American Journal of Veterinary Research, Vol. 61, No. 5, Pp. 537-543, 2000.10.2460/ajvr.2000.61.53710803649Search in Google Scholar

[42] N. Dodman, N. Blondeau, A.M. Marini, “Association of phenylbutazone usage with horses bought for slaughter: a public health risk”, Food and chemical toxicology, Vol. 48, No. 5, Pp. 1270-1274, 2010.Search in Google Scholar

[43] J.R. Martínez Aranzales, B.S. Cândido de Andrade, G.E. Silveira Alves, “Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa”, Journal of veterinary pharmacology and therapeutics, Vol. 38, No. 3, Pp. 257-264, 2015.10.1111/jvp.1216825287371Search in Google Scholar

[44] A.K. Rötting, D.E. Freeman, P.D. Constable, J.A.C. Eurell, M.A. Wallig, “Effects of phenylbutazone, indomethacin, prostaglandin E2, butyrate, and glutamine on restitution of oxidant-injured right dorsal colon of horses in vitro”, American journal of veterinary research, Vol. 65, No. 11, Pp. 1589-1595, 2004.Search in Google Scholar

[45] J.L. Baldwin, R. Storb, E.D. Thomas, M. Mannik, “Bone marrow transplantation in patients with gold-induced marrow aplasia”, Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, Vol. 20, No. 5, Pp. 1043-1048, 1977.Search in Google Scholar

[46] J.R. Martínez Aranzales, B.S. Cândido de Andrade, G.E. Silveira Alves, “Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa”, Journal of veterinary pharmacology and therapeutics, Vol. 38, No. 3, Pp. 257-264, 2015.10.1111/jvp.12168Search in Google Scholar

[47] K.L. Durrant, “Known and hidden sources of caffeine in drug, food, and natural products”, Journal of the American Pharmaceutical Association, Vol. 42, No. 4, Pp. 625-637, 2002.10.1331/10865800276302960712150361Search in Google Scholar

[48] V.G. Lizogub, D.S. Riley, M. Heger, “Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial”, EXPLORE: the Journal of Science and Healing, Vol. 3, No. 6, Pp. 573-584, 2007. Retrived from https://www.adk.gov.my/wp-content/uploads/Buku-Dasar-Dadah-Negara-EN.pdf10.1016/j.explore.2007.09.00418005909Search in Google Scholar

[49] C.J. Sinclair, J.D. Geiger, “Caffeine use in sports”, A pharmacological review. J Sports Med Phys Fitness, Vol. 40, No. 1, Pp. 71-79, 2000.Search in Google Scholar

[50] S. Cappelletti, P. Daria, G. Sani, M. Aromatario, “Caffeine: cognitive and physical performance enhancer or psychoactive drug”, Current neuropharmacology, Vol. 13, No. 1, Pp. 71-88, 2015.10.2174/1570159X13666141210215655446204426074744Search in Google Scholar

[51] M.A. Hassali, A.H. Mohamad Yahaya, A.A. Shafie, F. Saleem, G.N. Chua, H. Aljadhey, “Patterns and predictors of nonprescription medicine use among Malaysian pharmacy patrons: A national cross sectional study”, PLoS One, 8:e59231, 2013.10.1371/journal.pone.0059231361600823573195Search in Google Scholar

[52] C.P. Chong, S.F. Tan, W.T. Chooi, “An Evaluation on Consumers’ Usage Pattern of Acetaminophen (Paracetamol): A Multicenter Study from Penang, Malaysia”, Archives of Pharmacy Practice, Vol. 8, No. 1, 2017. Retrived from https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/pfukkm-2-2015-jun.pdf10.4103/2045-080X.199617Search in Google Scholar

[53] R.C. Dart, A.R. Erdman, K.R. Olson, G. Christianson, A.S. Manoguerra, P.A. Chyka, “Acetaminophen poisoning: An evidence-based consensus guideline for out of hospital management”, Clin Toxicol (Phila)., Vol. 44, No. 1, Pp. 18, 2006.10.1080/1556365050039457116496488Search in Google Scholar

[54] A.M. Larson, “Acetaminophen hepatotoxicity”, Clinics in liver disease, Vol. 11, No. 3, Pp. 525-548, 2007.10.1016/j.cld.2007.06.00617723918Search in Google Scholar

[55] A, Abdullah, “Difference between Halal and Halalan-Toyyiban”, International Institute of Advanced Islamic Studies (IAIS) Malaysia https://www.nst.com.my/opinion/columnists/2018/04/357046/difference-between-halaland-halalan-toyyiban, 2018.Search in Google Scholar

[56] J.R. Mora, M. Iwata, U.H. Von Andrian, “Vitamin effects on the immune system: vitamins A and D take centre stage”, Nature Reviews Immunology, Vol. 8, No. 9, Pp. 685, 2008.10.1038/nri2378290667619172691Search in Google Scholar

[57] E.N. Omar, H.S. Jaafar, M.R. Osman, F. Nasruddin, Halalan Toyyiban supply chain the new insights in sustainable supply chain management, 2013.10.24191/jeeir.v1i3.9127Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo